Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obervation Letter
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Letter to the Editor
2010:76:3;291-293
doi: 10.4103/0378-6323.62985
PMID: 20445309

Dupuytren's disease

Sanjay Saraf
 Department of Plastic Surgery, NMC Specialty Hospital, Dubai, United Arab Emirates

Correspondence Address:
Sanjay Saraf
Department of Plastic Surgery, NMC Specialty Hospital,Dubai
United Arab Emirates
How to cite this article:
Saraf S. Dupuytren's disease. Indian J Dermatol Venereol Leprol 2010;76:291-293
Copyright: (C)2010 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Dupuytren′s disease is a fibro-proliferative disorder of unknown etiology, often leading to disabling contractures of the hand. We report a case of Dupuytren′s contracture with review of etio-pathology, clinical presentation and management.

A 34-year-old Asian manual laborer presented with progressively worsening contracture of seven years duration involving right ring finger, lately affecting his job. There was no history suggestive of trauma, burns and collagen vascular disease. There was no familial history, no history of diabetes, epilepsy, alcohol consumption and smoking. Physical examination revealed thickening of right palmar aponeurosis with contracture of the finger. There was no detectable joint swelling, tenderness or knuckle pads. Routine laboratory investigations showed no abnormality. The X-ray of the hand was suggestive of flexion deformity of the ring finger with well preserved joint space. In view of significant morbidity; surgical intervention with limited regional fasciectomy technique was done with satisfactory result [Figure - 1],[Figure - 2],[Figure - 3],[Figure - 4].

Dupuytren′s disease is a disorder of the connective tissue primarily affecting the palmar and digital fascia often leading to disabling contractures of the metacarpophalangeal (MCP) and proximal interphangeal (PIP) joints of the hand.

The condition was first introduced in 1777 by Henry Cline into the medical literature, however, Dupuytren′s contracture is named after a French anatomist and surgeon Baron Guillaume Dupuytren who described the condition in detail in 1834. [1],[2]

The etiology of Dupuytren′s disease is still unknown. Genetics probably plays an important role and alcoholism, diabetes mellitus, epilepsy and HIV are considered to be significant risk factors for development of this disabling condition. There is a reported positive family history, which provides strong evidence for a genetic influence with many studies suggesting an autosomal dominant pattern of inheritance with variable penetrance. [3],[4] Studies have shown that persons of any race can be affected. [5]

Dupuytren′s disease usually has bilateral involvement, however, in unilateral cases, the right side is affected more often than the left. The ring finger is usually affected first, followed by the little finger, and then the middle finger. The disease is six to 10 times more frequent in males than in females.

The progression of the disease occurs in stages. Initially in proliferative stage, nodules develop in the palmar fascia which are known to be the pathognomonic lesion of Dupuytren′s contracture and are composed of fibroblasts and type III collagen. With further progression of disease the nodules become a thickened fibrous cord underneath the skin which later thickens and shortens in the active contractile, or involutional stage leading to the development of contractures. [6] The basic pathophysiology of Dupuytren′s contracture remains myofibroblast proliferation with increased water levels, type III collagen, chondroitin sulfate, reducible cross-linkages fibroblast proliferation and collagen deposition. The exact cause of uncontrolled proliferation remains unknown, however, many studies have implicated increased expression of growth factors, including basic fibroblast growth factor, platelet-derived growth factor, and transforming growth factor-beta for these changes. [7],[8]

The management of Dupuytren′s remains challenging and needs to be individualized. Various medical and surgical modalities have been described depending upon the severity of the symptoms. Usually, asymptomatic cases are better managed with conservative management, while symptomatic disabling cases are indications for surgery.

The non-surgical approach includes splinting, skeletal traction, steroids, calcium channel blockers, dimethylsulfoxide, vitamin E, allopurinol, ultrasound, laser therapy, radiation, Vitamin E and collagenolytic fasciotomy. However, they have not been proven to be of long-term value unless combined with surgical treatment. [9] Steroids do not stop progression of the disease but are often effective in reducing symptoms. A study showed that injections with triamcinolone acetonide (Kenalog), monthly, for up to five months, or every six weeks for up to three injections, followed by a six-month respite lead to significant disease regression. [10]

The role of IFN (interferon) alpha and gamma is also being evaluated and some preliminary studies have found encouraging results. [11],[12] Needle fasciotomy is a quick minimally invasive procedure with no down time. However the chances of recurrence are high and are not effective in treating severe Dupuytren′s contracture.

Surgically, excision or incision of the diseased fascia remains the cornerstone of the treatment. The presence of palmar nodule and cord in early stage are not necessarily indications for surgery. A MCP joint contracture and PIP joint contracture of 30 degrees or more is considered to be an indication for surgery. [13] Fasciectomy is the most preferred procedure. The various types of fasciectomy operations described are open fasciectomy (radical), dermofasciectomy and regional fasciectomy. [14] Regional (Selective/Limited) fasciectomy involves excising only grossly involved fascia and is one of the most commonly employed surgical technique with low morbidity and low recurrence rates. However, none of the treatment modalities cure the disease. They only help in preventing further progression of the disease. In near future, further medical advances in genetic engineering might help in stopping or reversing the progression of the disease at cellular level and the ongoing research will form the foundation for future clinical interventions.

References
1.
Dupuytren BG. Permanent retraction of the fingers, produced by an affection of the palmar fascia. Lancet 1834;2:222-5.
[Google Scholar]
2.
Townley WA, Baker R, Sheppard N, Grobbelaar AO. Dupuytren's contracture unfolded. BMJ 2006;332:397-400.
[Google Scholar]
3.
Saar JD, Grothaus PC. Dupuytren's disease: an overview. Plast Reconstr Surg 2000;106:125-34.
[Google Scholar]
4.
Burge P. Genetics of Dupuytren's disease. Hand Clin 1999;15:63-71.
[Google Scholar]
5.
Gonzalez MH, Sobeski J, Grindel S, Chunprapaph B, Weinzweig N. Dupuytren's disease in African-Americans. J Hand Surg Br 1998;23:306-7.
[Google Scholar]
6.
Seyhan H, Kopp J, Schultze-Mosgau S, Horch RE. Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture. Plast Reconstr Surg 2006;117:1248-52.
[Google Scholar]
7.
Tomasek JJ, Vaughan MB, Haaksma CJ. Cellular structure and biology of Dupuytren's disease. Hand Clin 1999;15:21-34.
[Google Scholar]
8.
James WD, Odom RB. The role of the myofibroblast in Dupuytren's contracture. Arch Dermatol 1980;116:807-11.
[Google Scholar]
9.
Hurst LC, Badalamente MA. Nonoperative treatment of Dupuytren's disease. Hand Clin 1999;15:97-107.
[Google Scholar]
10.
Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg 2000;25:1157-62.
[Google Scholar]
11.
Sanders JL, Dodd C, Ghahary A, Scott PG, Tredget EE. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture. J Hand Surg Am 1999;3:578-85.
[Google Scholar]
12.
Nedelec B, Shen YJ, Ghahary A, Scott PG, Tredget EE. The effect of interferon alpha 2b on the expression of cytoskeletal proteins in an in vitro model of wound contraction. J Lab Clin Med 1995;126:474-84.
[Google Scholar]
13.
McFarlane RM. Dupuytren's disease. In: McCarthy JG May JW, Littler JW, eds. Plastic Surgery. Vol 8, 1st ed. Philadelphia: WB Saunders; 1990. p. 5053-8.
[Google Scholar]
14.
McGrouther DA: Dupuytren's contracture. In Green DP, Hotchkiss RN, Pederson WC, eds: Operative Hand Surgery, vol 1, 4th ed. New York: Churchill Livingstone; 1998. p. 563-91.
[Google Scholar]

Fulltext Views
134

PDF downloads
118
Show Sections